Generate Biomedicines, Inc. (GENB) - Not Halal (Non-Compliant)
Generate Biomedicines, Inc. (GENB) is classified as Not Halal (Non-Compliant) according to AAOIFI Shariah screening standards. This assessment is based on business activity screening and financial ratio analysis using the AAOIFI methodology.
Business Activity Screen
- Sector
- Healthcare
- Industry
- Biotechnology
- Result
- Pass
- Reason
- The sector "Healthcare" and industry "Biotechnology" are not in the excluded categories.
Financial Ratios
- Debt Ratio
- Value: 3.9% | Threshold: 30% | Result: Pass
- Cash & Interest-bearing Securities Ratio
- Value: 28.4% | Threshold: 30% | Result: Pass
- Non-Permissible Income Ratio
- Value: 42.8% | Threshold: 5% | Result: Fail
Dividend Purification
Purification percentage: 42.83%.Based on the company's financial statements, approximately 42.83% of dividend income should be donated to charity for purification. This is derived from identified interest income (42.83% of total income). Some scholars may differ on the exact calculation method.
About Generate Biomedicines, Inc.
Generate Biomedicines, Inc., engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics in the United States. It uses protein-based modalities for drug development. Its product includes GB-0895, is an investigational long-acting anti-TSLP monoclonal antibody in development for severe asthma that is intended to be dosed every six months; GB-4362, an MMAE payload neutralizer monoclonal antibody; GB-5267, A MUC16 CAR-T Cell therapy. In additional, it develops Generate Platform, designed to be a therapeutic area and protein modality agnostic system integrating computational innovation with scalable biohardware to address therapeutic challenges beyond the reach of traditional technologies. Generate Biomedicines, Inc. was formerly known as Generate Biologics, Inc. and changed its name to Generate Biomedicines, Inc. in February 2020. The company was incorporated in 2018 and is based in Somerville, Massachusetts.
Frequently Asked Questions
Is Generate Biomedicines, Inc. (GENB) stock halal to invest in?
According to AAOIFI Shariah screening standards, Generate Biomedicines, Inc. (GENB) is currently classified as Not Halal (Non-Compliant). This is based on both business activity and financial ratio screening.